Clinical Trial Update: A COMPREHENSIVE BIOMARKER EVALUATION IN BILIARY TRACT CANCER

View source ↗

Summary

A comprehensive biomarker evaluation study in biliary tract cancer sponsored by MedSIR is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer

Snippet

Sponsor: MedSIR | Conditions: Biliary Tract Cancer (BTC) | Status: NOT_YET_RECRUITING